EUVIMEDEUVIMED entdecken
Multizentrische StudieKlinische Studie

An innovative, highly conformable, mesh-free healing matrix dressing: results of a clinical trial

Sylvie Meaume, Franck Duteille, Emmanuelle Bourrat, Florent Sala, Olivier Beatrix, Sophie Blaise, Azeddine Addala, Juliette Mazereeuw-Hautier, Raphaël Sinna, Philippe Leger, Julie Malloizel, Clémence Tumba und 3 weitere

Journal of Wound Care · 2025

DOI: 10.12968/jowc.2025.0356 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Wound Care, 2025. Verfasst von Sylvie Meaume und 14 weiteren Autor:innen. Beteiligte Einrichtung: Geriatric Department, Rothschild University Hospital, Paris, France. Hauptthemen laut MEDLINE: Wound Healing, Bandages, Wounds and Injuries. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The aim of this clinical trial was to evaluate the performance and local tolerance of an innovative mesh-free contact layer (healing matrix) made of lipidocolloid technology (TLC) in the management of various wounds. This dressing is made highly flexible by the absence of textile mesh in its core.

Method

A four-week, prospective, multicentre clinical trial was conducted on the evaluated dressing (UrgoFit, Laboratoires Urgo, France) in 23 centres in France. Eligible patients were adults with a cutaneous wound of acute or chronic origin or due to epidermolysis bullosa (EB) in the granulation stage. The primary endpoint was the relative wound area reduction (RWAR) at week 4. Secondary endpoints included wound closure rate and time-to-heal, as well as dressing change frequency, pain at dressing removal, local tolerance and acceptability of the dressing.

Results

A total of 78 adult patients (23–95 years old) were treated with the dressing over a period of 24±8 days. Wound aetiologies included: postoperative or traumatic finger wounds; skin graft donor sites; dermabrasions/skin tears; burns; leg ulcers (LUs) of predominantly venous origin; a stage 3 pressure injury; and EB lesions. The median RWAR at week 4 was 98.2% (ranging between 61.5–100.0%, depending on wound types). Complete closure was achieved in 49% of patients (59% in acute wounds, 60% in EB lesions and 16% in chronic wounds) with a median time-to-heal of 16.5 days (ranging between 14.5–27.0 days, depending on wound types). Half of LUs reached a RWAR ≥40% at week 4, a predictive indicator of complete wound healing at week 24. Dressings were changed every 2±1 days on average (and left in place for a maximum of 10 days). Since the first application, the dressing was judged by healthcare professionals (HCPs) to be ‘very easy’ or ‘easy’ to apply on 96% of wounds, with a ‘very good’ or ‘good’ conformability to 94% of wound beds. Similar results were reported in cases of finger/hand wounds. Since the first week of treatment, the dressing removal was also judged ‘very easy’ or ‘easy’ in 95–98% of the cases, protecting and preserving newly formed tissue in 100% of cases. At the first follow-up visit, patients reported the dressing changes to be painless in 95% of cases. This represented a significant improvement over the previous dressings they received (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Wound HealingBandagesWounds and InjuriesHumansMiddle AgedAdultMaleFemaleProspective StudiesAgedAged, 80 and overYoung AdultFranceEpidermolysis BullosaTreatment Outcome

Stichwörter der Autor:innen

TLC dressingsclinical trialconformabilityepidermolysis bullosafingershandlipidocolloid technology dressingswoundwound carewound dressingwound healing

Autor:innen und Institutionen

  • Geriatric Department, Rothschild University Hospital, Paris, France.
  • Plastic and Reconstructive Surgery and Burns Department, Hôtel-Dieu University Hospital, Nantes, France.
  • Department of Dermatology, Saint-Louis Hospital, Paris, France.
  • Vascular Surgery Department, Montréal Polyclinic, Carcassonne, France.
  • General and Oncology Surgery Department, Lyon Sud Hospital HCL, Lyon, France.
  • Department of Vascular Medicine, Albert Michalon University Hospital, Grenoble, France.

ORCID-Profile: Laetitia Thomassin

Zitieren

APA

Meaume, S., Duteille, F., Bourrat, E., Sala, F., Beatrix, O., Blaise, S., Addala, A., Mazereeuw-Hautier, J., Sinna, R., Leger, P., Malloizel, J., Tumba, C., Thomassin, L., Tacca, O., & Colboc, H. (2025). An innovative, highly conformable, mesh-free healing matrix dressing: results of a clinical trial. Journal of Wound Care. https://doi.org/10.12968/jowc.2025.0356

Vancouver

Meaume S, Duteille F, Bourrat E, Sala F, Beatrix O, Blaise S, et al. An innovative, highly conformable, mesh-free healing matrix dressing: results of a clinical trial. Journal of Wound Care. 2025. doi:10.12968/jowc.2025.0356

BibTeX
@article{Meaume2025,
  author = {Meaume, Sylvie and Duteille, Franck and Bourrat, Emmanuelle and Sala, Florent and Beatrix, Olivier and Blaise, Sophie and Addala, Azeddine and Mazereeuw-Hautier, Juliette and Sinna, Raphaël and Leger, Philippe and Malloizel, Julie and Tumba, Clémence and Thomassin, Laetitia and Tacca, Olivier and Colboc, Hester},
  title = {An innovative, highly conformable, mesh-free healing matrix dressing: results of a clinical trial},
  journal = {Journal of Wound Care},
  year = {2025},
  doi = {10.12968/jowc.2025.0356}
}
Kostenlos starten →